Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart H Ralston

Showing results (131-140 of 275) with videos related to

Pageof 28
Sort By:
Calcified Tissue International|April 19, 2021
Correction to: Targeted Inactivation of Rin3 Increases Trabecular Bone Mass by Reducing Bone Resorption and Favouring Bone FormationMahéva Vallet, Antonia Sophocleous, Anna E Törnqvist, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 26, 2010
Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of boneMicaela Rios Visconti, Anne L Langston, Nerea Alonso, et al.
The American Journal of Clinical Nutrition|May 13, 2008
Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphismsHelen M Macdonald, Fiona E McGuigan, Susan A Lanham-New, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 10, 2004
Identification of biphenylcarboxylic acid derivatives as a novel class of bone resorption inhibitorsRob J Van 't Hof, Aymen I Idris, Susan A Ridge, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 18, 2007
Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget's disease of boneStuart H Ralston, Muhammad A Afzal, Miep H Helfrich, et al.
Disease Models & Mechanisms|March 1, 2022
The Paget's disease of bone risk gene PML is a negative regulator of osteoclast differentiation and bone resorptionSachin Wani, Anna Daroszewska, Donald M Salter, et al.
Annals of the Rheumatic Diseases|October 8, 2013
Identification of small molecule inhibitors of RANKL and TNF signalling as anti-inflammatory and antiresorptive agents in miceEmmanuel Coste, Iain R Greig, Patrick Mollat, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 15, 2005
Loss of ubiquitin-binding associated with Paget's disease of bone p62 (SQSTM1) mutationsJames R Cavey, Stuart H Ralston, Lynne J Hocking, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 9, 2017
Long-Term Randomized Trial of Intensive Versus Symptomatic Management in Paget's Disease of Bone: The PRISM-EZ StudyAdrian Tan, Kirsteen Goodman, Allan Walker, et al.
Cell Reports|November 4, 2015
Optineurin Negatively Regulates Osteoclast Differentiation by Modulating NF-κB and Interferon Signaling: Implications for Paget's DiseaseRami Obaid, Sachin E Wani, Asim Azfer, et al.
Pageof 28

Showing results (131-140 of 275) with videos related to

Sort By:
Pageof 28
Calcified Tissue International|April 19, 2021
Correction to: Targeted Inactivation of Rin3 Increases Trabecular Bone Mass by Reducing Bone Resorption and Favouring Bone FormationMahéva Vallet, Antonia Sophocleous, Anna E Törnqvist, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 26, 2010
Mutations of SQSTM1 are associated with severity and clinical outcome in paget disease of boneMicaela Rios Visconti, Anne L Langston, Nerea Alonso, et al.
The American Journal of Clinical Nutrition|May 13, 2008
Vitamin K1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphismsHelen M Macdonald, Fiona E McGuigan, Susan A Lanham-New, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 10, 2004
Identification of biphenylcarboxylic acid derivatives as a novel class of bone resorption inhibitorsRob J Van 't Hof, Aymen I Idris, Susan A Ridge, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 18, 2007
Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget's disease of boneStuart H Ralston, Muhammad A Afzal, Miep H Helfrich, et al.
Disease Models & Mechanisms|March 1, 2022
The Paget's disease of bone risk gene PML is a negative regulator of osteoclast differentiation and bone resorptionSachin Wani, Anna Daroszewska, Donald M Salter, et al.
Annals of the Rheumatic Diseases|October 8, 2013
Identification of small molecule inhibitors of RANKL and TNF signalling as anti-inflammatory and antiresorptive agents in miceEmmanuel Coste, Iain R Greig, Patrick Mollat, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 15, 2005
Loss of ubiquitin-binding associated with Paget's disease of bone p62 (SQSTM1) mutationsJames R Cavey, Stuart H Ralston, Lynne J Hocking, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 9, 2017
Long-Term Randomized Trial of Intensive Versus Symptomatic Management in Paget's Disease of Bone: The PRISM-EZ StudyAdrian Tan, Kirsteen Goodman, Allan Walker, et al.
Cell Reports|November 4, 2015
Optineurin Negatively Regulates Osteoclast Differentiation by Modulating NF-κB and Interferon Signaling: Implications for Paget's DiseaseRami Obaid, Sachin E Wani, Asim Azfer, et al.
Pageof 28